{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:30:08Z","timestamp":1764682208333,"version":"3.46.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007319","name":"Albert Einstein College of Medicine, Yeshiva University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mrfmmm.2015.10.005","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T16:06:55Z","timestamp":1446653215000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting"],"prefix":"10.1016","volume":"782","author":[{"given":"Elaine","family":"Maggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0005","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.mrfmmm.2015.10.005_bib0010","article-title":"Chromosomal rearrangements in cancer: detection and potential causal mechanisms","volume":"1","author":"Hasty","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0015","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/bcj.2013.26","article-title":"Lessons from next-generation sequencing analysis in hematological malignancies","volume":"3","author":"Braggio","year":"2013","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.mrfmmm.2015.10.005_bib0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat. Genet."},{"issue":"7137","key":"10.1016\/j.mrfmmm.2015.10.005_bib0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mrfmmm.2015.10.005_bib0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7337","key":"10.1016\/j.mrfmmm.2015.10.005_bib0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.mrfmmm.2015.10.005_bib0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mrfmmm.2015.10.005_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.mrfmmm.2015.10.005_bib0050","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2008-05-155374","article-title":"Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach","volume":"112","author":"Roeder","year":"2008","journal-title":"Blood"},{"issue":"5906","key":"10.1016\/j.mrfmmm.2015.10.005_bib0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"issue":"7330","key":"10.1016\/j.mrfmmm.2015.10.005_bib0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0065","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mrfmmm.2015.10.005_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/gm451","article-title":"Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics","volume":"5","author":"Landau","year":"2013","journal-title":"Genome. Med."},{"issue":"26","key":"10.1016\/j.mrfmmm.2015.10.005_bib0075","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mrfmmm.2015.10.005_bib0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.mrfmmm.2015.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.mrfmmm.2015.10.005_bib0090","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.18632\/oncotarget.4214","article-title":"Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma","volume":"6","author":"Siegel","year":"2015","journal-title":"Oncotarget"},{"issue":"243","key":"10.1016\/j.mrfmmm.2015.10.005_bib0095","doi-asserted-by":"crossref","first-page":"243fs26","DOI":"10.1126\/scitranslmed.3009586","article-title":"Functional genomics for personalized cancer therapy","volume":"6","author":"Tyner","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.mrfmmm.2015.10.005_bib0100","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1101\/gr.189621.115","article-title":"The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing","volume":"25","author":"Cieslik","year":"2015","journal-title":"Genome Res."},{"issue":"7467","key":"10.1016\/j.mrfmmm.2015.10.005_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mrfmmm.2015.10.005_bib0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutationprofiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J. Mol. Diagn."},{"issue":"7","key":"10.1016\/j.mrfmmm.2015.10.005_bib0115","doi-asserted-by":"crossref","first-page":"e0133742","DOI":"10.1371\/journal.pone.0133742","article-title":"Development of a targeted multi-disorder high-throughput sequencing assay for the effective identification of disease-causing variants","volume":"10","author":"Delio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0120","unstructured":"Society, A.C., Cancer Facts & Figures 2015, in Atlanta: American Cancer Society, 2015."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0125","article-title":"Precision medicine to improve survival without increasing costs in advanced cancer patients","author":"Nadauld","year":"2015","journal-title":"ASCO Meeting Abstracts"},{"issue":"283","key":"10.1016\/j.mrfmmm.2015.10.005_bib0130","doi-asserted-by":"crossref","first-page":"283ra53","DOI":"10.1126\/scitranslmed.aaa7161","article-title":"Personalized genomic analyses for cancer mutation discovery and interpretation","volume":"7","author":"Jones","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.mrfmmm.2015.10.005_bib0135","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0140","article-title":"A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer","author":"Sukhai","year":"2015","journal-title":"Genet. Med."},{"issue":"12","key":"10.1016\/j.mrfmmm.2015.10.005_bib0145","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","article-title":"Prioritizing targets for precision cancer medicine","volume":"25","author":"Andre","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2015.05.013","article-title":"The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform","author":"Johnson","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.mrfmmm.2015.10.005_bib0155","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-014-0069-3","article-title":"Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients","volume":"6","author":"Scollon","year":"2014","journal-title":"Genome. Med."},{"issue":"4","key":"10.1016\/j.mrfmmm.2015.10.005_bib0160","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mrfmmm.2015.10.005_bib0165","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1373\/clinchem.2014.234286","article-title":"Rapid identification of plasma DNA samples with Increased ctDNA levels by a modified FAST-SeqS approach","volume":"61","author":"Belic","year":"2015","journal-title":"Clin. Chem."},{"issue":"224","key":"10.1016\/j.mrfmmm.2015.10.005_bib0170","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.mrfmmm.2015.10.005_bib0175","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat. Med."},{"issue":"179","key":"10.1016\/j.mrfmmm.2015.10.005_bib0180","doi-asserted-by":"crossref","first-page":"179ra47","DOI":"10.1126\/scitranslmed.3005616","article-title":"Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells","volume":"5","author":"Ozkumur","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"18","key":"10.1016\/j.mrfmmm.2015.10.005_bib0185","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-06-0436","article-title":"The use of targeted mouse models for preclinical testing of novel cancer therapeutics","volume":"12","author":"Olive","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.mrfmmm.2015.10.005_bib0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.mrfmmm.2015.10.005_bib0195","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.celrep.2014.08.029","article-title":"Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells","volume":"8","author":"Ting","year":"2014","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.mrfmmm.2015.10.005_bib0200","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/0008-5472.CAN-12-2799","article-title":"Clonal progression of prostate cancers from Gleason grade 3 to grade 4","volume":"73","author":"Sowalsky","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mrfmmm.2015.10.005_bib0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1541-7786.MCR-14-0273","article-title":"Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer","volume":"13","author":"Sowalsky","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.mrfmmm.2015.10.005_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/gm434","article-title":"Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med."},{"issue":"20","key":"10.1016\/j.mrfmmm.2015.10.005_bib0215","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0220","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.62.4726","article-title":"Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer","author":"Grisham","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"6104","key":"10.1016\/j.mrfmmm.2015.10.005_bib0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Iyer","year":"2012","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mrfmmm.2015.10.005_bib0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Wagle","year":"2014","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.mrfmmm.2015.10.005_bib0235","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMoa1403352","article-title":"Response and acquired resistance to everolimus in anaplastic thyroid cancer","volume":"371","author":"Wagle","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mrfmmm.2015.10.005_bib0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/cns.13.21","article-title":"An integrated approach to identifying clinically relevant targets in pediatric gliomas","volume":"2","author":"McEachron","year":"2013","journal-title":"CNS Oncol."},{"issue":"9","key":"10.1016\/j.mrfmmm.2015.10.005_bib0245","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/2159-8290.CD-14-0380","article-title":"Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy","volume":"4","author":"Al-Ahmadie","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003086-199101000-00002","article-title":"The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases 1893","volume":"262","author":"Coley","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"7484","key":"10.1016\/j.mrfmmm.2015.10.005_bib0255","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.mrfmmm.2015.10.005_bib0260","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6230","key":"10.1016\/j.mrfmmm.2015.10.005_bib0265","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"6236","key":"10.1016\/j.mrfmmm.2015.10.005_bib0270","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"Cancer immunotherapy a dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"issue":"177","key":"10.1016\/j.mrfmmm.2015.10.005_bib0275","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy\u2013refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.mrfmmm.2015.10.005_bib0280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12185-013-1479-5","article-title":"Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies","volume":"99","author":"Davila","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.mrfmmm.2015.10.005_bib0285","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"6","author":"Niederst","year":"2015","journal-title":"Nat. Commun."},{"issue":"49","key":"10.1016\/j.mrfmmm.2015.10.005_bib0290","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.mrfmmm.2015.10.005_bib0295","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat. Genet."},{"issue":"6216","key":"10.1016\/j.mrfmmm.2015.10.005_bib0300","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Crystal","year":"2014","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.mrfmmm.2015.10.005_bib0305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1158\/2159-8290.CD-15-0399","article-title":"Heterogeneity underlies the emergence of EGFRT790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor","volume":"5","author":"Piotrowska","year":"2015","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.mrfmmm.2015.10.005_bib0310","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13059-014-0438-7","article-title":"Organizing knowledge to enable personalization of medicine in cancer","volume":"15","author":"Good","year":"2014","journal-title":"Genome Biol."},{"issue":"111","key":"10.1016\/j.mrfmmm.2015.10.005_bib0315","doi-asserted-by":"crossref","first-page":"111ra121","DOI":"10.1126\/scitranslmed.3003161","article-title":"Personalized oncology through integrative high-throughput sequencing: a pilot study","volume":"3","author":"Roychowdhury","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.mrfmmm.2015.10.005_bib0320","doi-asserted-by":"crossref","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.mrfmmm.2015.10.005_bib0325","doi-asserted-by":"crossref","first-page":"e0130393","DOI":"10.1371\/journal.pone.0130393","article-title":"Prevalence of germline mutations in genes engaged in DNA damage repair by homologous recombination in patients with triple-negative and hereditary non-triple-negative breast cancers","volume":"10","author":"Domagala","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mrfmmm.2015.10.005_bib0330","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2014.11.042","article-title":"Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer","volume":"148","author":"Grant","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.mrfmmm.2015.10.005_bib0335","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/bjc.2013.233","article-title":"Long noncoding RNAs and the genetics of cancer","volume":"108","author":"Cheetham","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.mrfmmm.2015.10.005_bib0340","doi-asserted-by":"crossref","first-page":"e69239","DOI":"10.1371\/journal.pone.0069239","article-title":"Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mrfmmm.2015.10.005_bib0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mrfmmm.2015.10.005_bib0350","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.oraloncology.2015.06.013","article-title":"Integrative genomic analysis of ghost cell odontogenic carcinoma","volume":"51","author":"Bose","year":"2015","journal-title":"Oral Oncol."},{"issue":"12","key":"10.1016\/j.mrfmmm.2015.10.005_bib0355","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nmeth.2689","article-title":"DGIdb: mining the druggable genome","volume":"10","author":"Griffith","year":"2013","journal-title":"Nat. Methods"}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510715300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510715300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:25:41Z","timestamp":1764681941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510715300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":71,"alternative-id":["S0027510715300506"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2015.10.005","relation":{},"ISSN":["1386-1964"],"issn-type":[{"type":"print","value":"1386-1964"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2015.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015  Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}